DPNJMUi001-A

The cell line is not validated yet.

General

Cell Line

hPSCreg name DPNJMUi001-A
Cite as:
DPNJMUi001-A (RRID:CVCL_C0CG)
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
SCVIi091-A
(SCVI2617)
Donor diseases:
transthyretin amyloidosis
KMUGMCi005-A
(KMUGMCi005TMC8, KN627)
Donor diseases:
Epidermodysplasia Verruciformis
INSRMi021-A
(PC177 3c14)
Donor diseases:
myofibrillar myopathy 1
KMUGMCi003-A
(KMUGMCi003ERCC2, KN610)
Donor diseases:
Trichothiodystrophy 1, Photosensitive
AIBNi016-A
(SPG2-S376C1)
Donor diseases:
hereditary spastic paraplegia 56
ITXi013-A
(PT-R406W)
Donor's gene variants:
DES
Donor diseases:
Desminopathy
ITXi013-B
(IC-R406)
Donor's gene variants:
DES
Donor diseases:
Desminopathy
CMCi001-A
(CMC-KIN-hiPSC)
Donor diseases:
karyomegalic interstitial nephritis
KSCBi010-A
(DKH005i-A, DKHi005-A)
Donor diseases:
Senior-Loken syndrome
PFIZi023-A
(B217c8)
Donor's gene variants:
GPR56, GPR56
Donor diseases:
Bilateral Frontoparietal Polymicrogyria
SZGJMSi001-A
(ZLP-2)
Donor diseases:
Schizophrenia
KMUGMCi004-A
(KMUGMCi004APC, KN615)
Donor diseases:
familial adenomatous polyposis
SCVIi108-A
(SCVI2767)
Donor diseases:
familial hypercholesterolemia
PFIZi032-A
(B214c8)
Donor's gene variants:
TSC2
Donor diseases:
Tuberous Sclerosis
ZJSHi001-A
(ZJSHi-KCNB1)
Donor's gene variants:
KCNB1
Donor diseases:
developmental and epileptic encephalopathy, 26
WCHi006-A
Donor diseases:
Schizophrenia
CABi003-A
(DH05, AMDdh05-MiPS4F16)
Donor diseases:
Age-Related Macular Degeneration
USPi006-A
(DFNA58-ipsc-dup1-cl2)
Donor diseases:
autosomal dominant nonsyndromic deafness 58
USPi007-A
(DFNA58-ipsc-dup2-cl5)
Donor diseases:
autosomal dominant nonsyndromic deafness 58
SCTCi011-A
(IPS18-00072)
Donor diseases:
age-related macular degeneration
IMAGINi022-A
(IMAGINE022)
Donor diseases:
Waardenburg syndrome
WCHi003-A
Donor diseases:
Schizophrenia
CMCi009-A
(CMC-BHD-001)
Donor's gene variants:
FLCN
Donor diseases:
Birt-Hogg-Dube Syndrome
SCTCi015-A
(IPS19-00051)
Donor diseases:
Age-Related Macular Degeneration
KMUGMCi001-A
(KMUGMCi001ACVRL1)
Donor diseases:
Telangiectasia, Hereditary Hemorrhagic
PCIi026-A
(PC085)
Donor diseases:
Waardenburg syndrome
IMBAi017-A
(B002-ARID1B#8, Pat.2 ARID1B+/- clone 2a (XX))
Donor diseases:
Coffin-Siris Syndrome
UOMi010-A
(ANCS-hiPSC-HPP5)
Donor diseases:
Hypophosphatasia
UOMi011-A
(ANCS-hiPSC-HPP6)
Donor diseases:
Hypophosphatasia
PCIi025-A
(PC084)
Donor diseases:
Waardenburg syndrome
PCIi032-A
(PC087)
Donor diseases:
Waardenburg Syndrome
Last update 14th March 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Children's Hospital of Nanjing Medical University (DPNJMU)

External Databases

BioSamples SAMEA13371559
Cellosaurus CVCL_C0CG
Wikidata Q112929464

General Information

Publications
* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • COXPD23
Family history No

Karyotyping (Donor)

Has the donor karyotype been analysed?
No

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
Yes
Exome sequencing

External Databases (Donor)

BioSamples SAMEA9699776

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? No
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Please provide contact information of the holder of the original Donor Information Sheet. A 5-year-old girl with hypertrophic cardiomyopathy and hyperlactatemia, .
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Alternatives to consent are available? No
Is there other documentation provided to the donor for consenting purposes? No
Confirm that consent was obtained by a qualified professional Yes
Has the donor agreed to be re-contacted? Unknown
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A sample of peripheral blood mononuclear cells.
Synonyms
  • Peripheral Blood Mononuclear Cell Specimen
  • PBMC Specimen
  • PBMC Sample
  • Peripheral Blood Mononuclear Cell Sample
  • Peripheral Blood Mononuclear Cell (PBMC)
show more synonyms

Reprogramming method

Vector type None

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzymatically
TrypLE
CO2 Concentration 5 %
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Differentiation Potency

Microbiology / Virus Screening

Certificate of Analysis

Is there a certificate of analysis available?
Yes
Passage:

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46XX
Passage number: 10
Karyotyping method: G-Banding

Other Genotyping (Cell Line)